Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC [Phase 2]
A Phase 2 trial evaluating maintenance therapy with Gleevec (imatinib) after induction irinotecan and cisplatin in patients with C-KIT posit…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: LBH Phase II in Small Cell Lung Cancer (SCLC) [Phase 2]
Phase II study of LBH in small cell lung cancer has completed. The document provides an update on the trial but does not include detailed re…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer [Phase 1, Phase 2]
The document notes a completed Phase 1/Phase 2 study evaluating AT-101 in combination with topotecan for relapsed/refractory small cell lung…
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer [Phase 2]
This update reports on a Phase 2 trial evaluating weekly topotecan as second-line therapy for small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer [Phase 2]
This document reports the completion of a Phase 2 trial evaluating weekly topotecan as first-line therapy for elderly patients with small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating weekly paclitaxel plus gemcitabine as second-line therapy for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of imatinib (Gleevec) with irinotecan (Camptosar) and cisplatin (Paraplatin) in previously untreat…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer [Phase 2]
A phase 2 clinical trial assessing the combination of irinotecan, carboplatin, bevacizumab, and radiation therapy for limited-stage small ce…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
This document summarizes the completion of a Phase 2 trial evaluating thalidomide in patients with extensive-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG [Phase 3]
This completed Phase III randomized trial in patients with limited-stage small cell lung cancer evaluated survival after vaccination with ad…
-
FDA approval · 2010-03-26FDA Approved: HYCAMTIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for HYCAMTIN (topotecan hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
An update on a second-line treatment trial for small cell lung cancer; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating neoadjuvant chemoradiotherapy followed by surgery for limited-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing irinotecan hydrochloride (Campto) plus cisplatin vs etoposide plus cisplatin in small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) [Phase 2]
A Phase 2 trial evaluating chemotherapy plus radiotherapy for limited-stage small cell lung cancer was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing pemetrexed plus carboplatin versus etoposide plus carboplatin in extensive-stage small cell lung cancer; results w…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. [Phase 2]
A Phase 2 randomized trial compared amrubicin to topotecan in patients with small cell lung cancer who had responded to prior therapy. The s…
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin [Phase 2]
Phase 2 trial evaluating weekly Hycamtin (topotecan) plus Paraplatin (cisplatin) as first-line therapy for extensive-disease small cell lung…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy [Phase 1, Phase 2]
A Phase 1/2 study evaluated cisplatin and pemetrexed with radiotherapy for small cell lung cancer; the trial was terminated and results were…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation [Phase 3]
A Phase 3 trial evaluating FDG-PET-CT scans to predict outcomes in lung cancer patients receiving concurrent chemoradiation has been termina…
-
CLINICAL_TRIALS research · 2009-06-17Clinical Trial Update: Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans
This clinical trial update reports on concurrent chemotherapy and radiotherapy for limited-disease small cell lung cancer guided by FDG-PET …
-
CLINICAL_TRIALS trial_result · 2009-05-25Clinical Trial Update: Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating pemetrexed plus cisplatin in small cell lung cancer; the study was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma [Phase 2]
Phase 2 safety and efficacy study of glufosfamide in patients with recurrent sensitive small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: Study of Picoplatin Efficacy After Relapse [Phase 3]
Phase 3 clinical trial update evaluating the efficacy of picoplatin after relapse in small cell lung cancer.
-
CLINICAL_TRIALS research · 2009-03-03Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update evaluating a monoclonal antibody therapy for relapsed or refractory small cell lung cancer.